logo

Nextcure Inc (NXTC)



Trade NXTC now with
  Date
  Headline
7/13/2020 6:12:45 AM NextCure Provides Interim Update For Phase 2 Portion Of NC318 Monotherapy Phase 1/2 Trial
5/29/2020 8:09:49 AM NextCure Presents Biomarker Data And Updated Clinical Results From Phase 1 Portion Of Its NC318 Clinical Trial
4/13/2020 7:08:58 AM NextCure: COVID-19 Pandemic Has Put Significant Strain On Clinical Trial Sites
3/30/2020 7:17:05 AM NextCure Names Garry Nicholson To Board Of Directors
11/15/2019 12:10:48 AM NextCure Announces Pricing Of Public Offering Of 4.08 Mln Shares At $36.75/Shr
11/14/2019 10:20:20 PM NextCure Prices Public Offering Of 4.08 Mln Shares At $36.75/shr
10/2/2019 7:38:34 AM NextCure Announces Promotion Timothy Mayer To COO
8/12/2019 4:11:29 PM NextCure Q2 Loss/share $0.61 Vs. Loss $3.82 Year Ago